AFTPH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.784400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.617600E-01
Normal-vs-Stage2
5.649600E-01
Normal-vs-Stage3
9.994000E-02
Normal-vs-Stage4
5.753000E-01
Stage1-vs-Stage2
1.803620E-01
Stage1-vs-Stage3
2.458000E-02
Stage1-vs-Stage4
6.732400E-01
Stage2-vs-Stage3
7.274100E-02
Stage2-vs-Stage4
9.654100E-02
Stage3-vs-Stage4
3.096000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.735600E-01
Normal-vs-AfricanAmerican
9.668200E-01
Normal-vs-Asian
3.930800E-01
Caucasian-vs-AfricanAmerican
3.818000E-01
Caucasian-vs-Asian
4.480000E-01
AfricanAmerican-vs-Asian
3.253600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.265000E-01
Normal-vs-Female
5.236600E-01
Male-vs-Female
6.706000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.254200E-01
Normal-vs-Age(41-60Yrs)
8.993600E-01
Normal-vs-Age(61-80Yrs)
4.349400E-01
Normal-vs-Age(81-100Yrs)
4.621400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.876200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.059800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.962000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.751800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.142400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.694400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.092600E-01
Normal-vs-Daily Drinker
3.106400E-01
Normal-vs-Weekly Drinker
2.889200E-01
Normal-vs-Occasional Drinker
9.672400E-01
Normal-vs-Social Drinker
6.381400E-01
Non Drinker-vs-Daily Drinker
5.774200E-01
Non Drinker-vs-Weekly Drinker
2.558600E-01
Non Drinker-vs-Occasional Drinker
1.338170E-01
Non Drinker-vs-Social Drinker
5.760600E-01
Daily Drinker-vs-Weekly Drinker
5.207400E-01
Daily Drinker-vs-Occasional Drinker
7.053800E-02
Daily Drinker-vs-Social Drinker
3.357000E-01
Weekly Drinker-vs-Occasional Drinker
4.978300E-02
Weekly Drinker-vs-Social Drinker
1.922600E-01
Occasional Drinker-vs-Social Drinker
4.457800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.341900E-03
Normal-vs-Grade 2
8.354900E-04
Normal-vs-Grade 3
4.043200E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.124800E-01
Grade 1-vs-Grade 3
5.644000E-01
Grade 1-vs-Grade 4
9.341900E-03
Grade 2-vs-Grade 3
8.764200E-01
Grade 2-vs-Grade 4
8.354900E-04
Grade 3-vs-Grade 4
4.043200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.807800E-01
Normal-vs-NonDiabetic
4.601000E-01
Diabetic-vs-NonDiabetic
7.841200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.565200E-01
Normal-vs-NoPancreatitis
4.861400E-01
Pancreatitis-vs-NoPancreatitis
8.193400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.186000E-01
Normal-vs-N1
5.902600E-01
N0-vs-N1
9.631400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.833400E-01
Normal-vs-TP53-NonMutant
9.838800E-01
TP53-Mutant-vs-TP53-NonMutant
9.965600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
